MedPath

A Study on Telemedicine Applied to Actual Outpatient Clinic for Epilepsy

Completed
Conditions
Epilepsy
Registration Number
NCT05418257
Lead Sponsor
Samsung Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Those who have received outpatient treatment for epilepsy at least twice from the<br> Department of Neurology, Department of Pediatrics, Samsung Medical Center as of the<br> date of participation in the study<br><br> - Those who have been taking one or more anticonvulsants for 3 months or more as of<br> the date of participation in the study<br><br> - Those who have passed more than one month from the date of discharge from the<br> hospital as of the date of participation in the study (However, hospitalization for<br> examination only does not fall under this standard)<br><br>Exclusion Criteria:<br><br> - Those who have an experience of inpatient treatment within 1 month as of the date of<br> participation in the study (However, hospitalization for examination only is not<br> classified as hospitalization under this standard)<br><br> - Those who have a record of visiting the emergency room within 1 month as of the date<br> of participation in the study (However, visits that are not for epilepsy drug<br> control are not classified as emergency room visits according to this standard)<br><br> - Those who have been diagnosed with psychogenic non-epileptic seizure (PNES) through<br> electroencephalogram (EEG)

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Seizure control - 1) Change from baseline seizure frequency at 6 months;Seizure control - 2) Change from baseline seizure type at 6 months
Secondary Outcome Measures
NameTimeMethod
adherence to treatment - 1) Medication compliance;adherence to treatment - 2) Outpatient visit compliance;Change from baseline adverse drugs reactions at 6 months
© Copyright 2025. All Rights Reserved by MedPath